AU5324500A - Hcv/bvdv chimeric genomes and uses thereof - Google Patents

Hcv/bvdv chimeric genomes and uses thereof

Info

Publication number
AU5324500A
AU5324500A AU53245/00A AU5324500A AU5324500A AU 5324500 A AU5324500 A AU 5324500A AU 53245/00 A AU53245/00 A AU 53245/00A AU 5324500 A AU5324500 A AU 5324500A AU 5324500 A AU5324500 A AU 5324500A
Authority
AU
Australia
Prior art keywords
hcv
chimeric genomes
bvdv
bvdv chimeric
genomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53245/00A
Inventor
Jens Bukh
Suzanne U Emerson
Jae-Hwan Nam
Robert H. Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU5324500A publication Critical patent/AU5324500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24341Use of virus, viral particle or viral elements as a vector
    • C12N2770/24344Chimeric viral vector comprising heterologous viral elements for production of another viral vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU53245/00A 1999-06-04 2000-06-02 Hcv/bvdv chimeric genomes and uses thereof Abandoned AU5324500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13781799P 1999-06-04 1999-06-04
US60137817 1999-06-04
PCT/US2000/015527 WO2000075352A2 (en) 1999-06-04 2000-06-02 Hcv/bvdv chimeric genomes and uses thereof

Publications (1)

Publication Number Publication Date
AU5324500A true AU5324500A (en) 2000-12-28

Family

ID=22479160

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53245/00A Abandoned AU5324500A (en) 1999-06-04 2000-06-02 Hcv/bvdv chimeric genomes and uses thereof

Country Status (3)

Country Link
EP (1) EP1187927A2 (en)
AU (1) AU5324500A (en)
WO (1) WO2000075352A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222661A1 (en) 2002-09-13 2006-10-05 Birke Bartosch Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
US20100129902A1 (en) * 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
US9775894B2 (en) 2013-07-09 2017-10-03 University Of Washington Through Its Center For Commercialization Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
CN103924006A (en) * 2014-04-21 2014-07-16 江苏省农业科学院 Primer sequence for detecting nucleotide fragment of HoBi-like pestivirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1071454A1 (en) * 1998-04-24 2001-01-31 Washington University Chimeras of hepatitis c virus and bovine viral diarrhea virus

Also Published As

Publication number Publication date
WO2000075352A2 (en) 2000-12-14
EP1187927A2 (en) 2002-03-20
WO2000075352A3 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2002353790A1 (en) Syringe and reconstitution syringe
AU2001280810A1 (en) Benzothiazepines and their use as antihyperlipidemics
AU1813901A (en) Chimeric flavivirus vaccines
AU2919001A (en) Syringe
AU1890300A (en) Novel interferon-alpha
AU2001274548A1 (en) Syringe
AU5617900A (en) Chimeric chemokine-antigen polypeptides and uses therefor
AU2001269474A1 (en) Phenylpyridazine Compounds and Medicines Containing the Same
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU1594601A (en) Manipulator
AU5179400A (en) Switching complex architecture and operation
AU1825300A (en) Chimeric biotin-binding papillomavirus protein
AU7716300A (en) Cleaning implements
AU2841801A (en) Triazolotriazinones and the use thereof
AU2002210916A1 (en) Endoscope attachment and endoscope
ZA200204047B (en) The genome of the HV-1 inter-subtype (C/B') and use thereof.
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU3978700A (en) Medical use
AU5324500A (en) Hcv/bvdv chimeric genomes and uses thereof
AU2002222139A1 (en) Hcv vaccines
AU5979300A (en) Angiopoietin-6 and uses thereof
AU6983000A (en) Chimeric proteins
AU2669201A (en) Taccalonolides and their use
AU1043601A (en) Medical use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase